Chemotherapy and targeted-therapy guided by organoid drug sensitivity test

OTHER4 trials

Sponsors

Ruijin Hospital, Henan Cancer Hospital, Tianjin Medical University Cancer Institute and Hospital

Conditions

Advanced Pancreatic Neuroendocrine TumorNon-small Cell Lung CancerRefractory Breast CancerSmall Cell Lung Cancer

Unknown Phase

In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

RecruitingNCT06246630

Ruijin HospitalAdvanced Pancreatic Neuroendocrine Tumor

Start: 2024-04-03End: 2026-06-25Target: 20Updated: 2024-05-16

Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer

RecruitingNCT06406608

Henan Cancer HospitalNon-small Cell Lung Cancer

Start: 2024-04-16End: 2026-06-16Target: 20Updated: 2024-05-09

Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer

RecruitingNCT06406660

Henan Cancer HospitalSmall Cell Lung Cancer

Start: 2024-04-16End: 2026-06-16Target: 20Updated: 2024-05-09

Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results

Not yet recruitingNCT06438055

Tianjin Medical University Cancer Institute and HospitalRefractory Breast Cancer

Start: 2024-06-30End: 2026-06-30Target: 40Updated: 2024-05-31